SGLT2 Inhibitors: Benefits and Risks

This chapter explores the use of SGLT2 inhibitors in treating diabetes and chronic kidney disease, referencing a significant Cochrane review involving over 65,000 adults. It discusses their effectiveness in preventing serious health conditions while addressing potential side effects and recent trends in opioid prescribing in primary care.